CL.CN Overview

Company Profile

Related stocks

AQST • United States

Aquestive Therapeutics, Inc.

4.78 USD

599.95M USD 1Y -23.2%

EOLS • United States

Evolus, Inc. Common Stock

7.73 USD

510.57M USD 1Y +25.6%

TLRY • Canada

Tilray Brands, Inc.

3.54 USD

523.15M USD 1Y -79.1%

ESPR • United States

Esperion Therapeutics, Inc.

3.18 USD

819.46M USD

CURA.TO • United States

CURALEAF HOLDINGS INC

13.31 CAD

2.47B USD 1Y -4.4%

COLL • United States

Collegium Pharmaceutical, Inc.

22.09 USD

719.15M USD 1Y -33.3%

AMPH • United States

Amphastar Pharmaceuticals, Inc.

26.62 USD

1.13B USD 1Y -0.7%

GTII.CN • United States

GreenThumb

9.58 CAD

1.47B USD 1Y -21.2%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

United States

Region

North America

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

101.5% p.a.

Max Drawdown (5Y)

-95.0%

Sharpe Ratio (5Y)

-0.40

Beta Factor

1.81

Size Class

Small Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Critical leverage: Debt-to-Equity is at 225%.

High market risk: Beta of 1.81 indicates above-average volatility compared to the broader market.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Elevated Short-Term Volatility: 3Y volatility (115.6%) is noticeably higher than the 5Y average (101.5%).

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (101.5% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -97.2% in the extended horizon.